BLK vs INMB · P/E 27, rev $24.22B vs rev $50.0K
BlackRock Inc (BLK) versus INmune Bio Inc (INMB) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. INMB currently screens at market cap $33.5M.
Not investment advice. Open the BLK and INMB stock pages for the full models.
Not investment advice.